Arbor Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Arbor Pharmaceuticals's estimated annual revenue is currently $22.5M per year.
- Arbor Pharmaceuticals's estimated revenue per employee is $201,000
- Arbor Pharmaceuticals's total funding is $40.4M.
Employee Data
- Arbor Pharmaceuticals has 112 Employees.
- Arbor Pharmaceuticals grew their employee count by -7% last year.
Arbor Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | V.P. Regulatory Affairs, Quality, and Manufacturing | Reveal Email/Phone |
4 | Director | Reveal Email/Phone |
5 | Senior Director Hospital & Specialty Marketing | Reveal Email/Phone |
6 | Director, Marketing | Reveal Email/Phone |
7 | Director Financial Planning and Analysis | Reveal Email/Phone |
8 | National Business Director Hospital Specialty | Reveal Email/Phone |
9 | Director, Clinical Development | Reveal Email/Phone |
10 | Director, Sales Operations | Reveal Email/Phone |
Arbor Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Arbor Pharmaceuticals?
Arbor Pharmaceuticals is dedicated to introducing and growing unique pharmaceutical brands that have features closely aligned with those desired by pediatricians and their patients. Specifically, Arbor will initially focus on acute care medicines that incorporate well characterized (safe and effective) molecules with novel delivery systems to enhance the product profile.
keywords:N/A$40.4M
Total Funding
112
Number of Employees
$22.5M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arbor Pharmaceuticals News
NovaQuest Capital's Azurity Pharmaceuticals Inc., its Arbor unit, and their business partner, Morgan Stanley's Comar LLC, filed a lawsuit...
Merck. Co., Inc, Galderma Laboratories, L.P., Arbor Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Medicines Development for Global...
"Plaintiffs Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd., and defendants Lupin Ltd. and Lupin Pharmaceuticals Inc.,...
Arbor Pharmaceuticals, an Atlanta, GA-based specialty pharmaceutical company, completed a $34.8m financing. This included a $17.5m investment in the form of Series B Preferred Stock led by Signet Healthcare Partners, LLC. The remainder of the financing was provided in the form of a term loan by ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $28.5M | 114 | 0% | N/A |
#2 | $16.8M | 116 | 5% | N/A |
#3 | $24.5M | 122 | 8% | N/A |
#4 | $34M | 126 | 42% | N/A |
#5 | $33.1M | 132 | 4% | N/A |